openPR Logo
Press release

Genomic Biomarkers Market Key Technology and Application Market (2017-2023)

02-11-2019 02:58 PM CET | Health & Medicine

Press release from: Allied Market Research

Genomic Biomarkers Market

Genomic Biomarkers Market

Biomarkers are minimally or non-invasive tools used in imaging technology to provide clear imaging of oncology tumors & other problems and also eliminate the chance of radiation exposure during imaging through CT scans and MRI scans. Genomic biomarkers are used to test high blood pressure, hyperkalemia, and other monogenic conditions. They reflect the expression of a gene, function of a gene, and regulation of a gene in normal biologic processes, pathogenic processes, and responses to therapeutics.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/4141

The major factors that contribute to the growth of the genomic biomarkers market include increasing prevalence of ovarian, gastric, and colorectal cancers, high demand for minimally invasive procedures, development of technologies in clinical laboratory tests, immense developments in infrastructure for data sharing and analysis such as bioinformatics, and growing awareness about genomics biomarker-based personalized medicines.

However, complex processes associated with genomics biomarker and stringent government regulations hamper the growth of the global genomic biomarkers market. Growing awareness about the role of biomarkers to diagnose fatal diseases such as cancer and cardiovascular diseases & reimbursement issues are being solved with the intervention of regulatory authorities, which is expected to propel the growth of the market in the near future.

The global genomic biomarkers market is segmented on the basis of application, end user, and region. On the basis of application, the market is segmented into oncology, cardiovascular diseases, neurological diseases, and others. On the basis of end user, the market is segmented into diagnostic & research laboratories, hospitals, and others. Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players that operate in this market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Aepodia SA, Myriad Genetics, Inc., Eurofins Scientific, QIAGEN, Bio-Rad Laboratories, Inc., Genomic Health, Liquid Genomics, Epigenomics AG, and AROS Applied Biotechnology A/S.

Key Benefits

• The study provides an in-depth analysis of the global genomic biomarkers market with current trends and future estimations to elucidate imminent investment pockets.
• The report provides information about the current and upcoming trends in the global genomic biomarkers market from 2016 to 2023, which helps determine prevailing opportunities.
• Comprehensive analysis of factors that drive and restrict the growth of the global genomic biomarkers market has been provided.
• Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale have been provided.
• Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the global genomic biomarkers market.

Genomic Biomarkers Market Key Segments:

By Application

• Oncology
• Cardiovascular diseases
• Neurological diseases
• Others

By End User

• Diagnostic and research laboratories
• Hospitals
• Others

For More Info Visit @ https://www.alliedmarketresearch.com/request-toc-and-sample/4141

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Genomic Biomarkers Market Key Technology and Application Market (2017-2023) here

News-ID: 1577593 • Views: 259

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Genomic

Cardiology Genomic Testing Market Impact Analysis By 2028
Heart disorders can be inherited and passed from parents to children via their genes. Cardiology genomic testing helps in detecting diseases such as aortopathy and congenital heart diseases. Also, it can be useful for family members who are at a risk of developing heart problems. Genetic disorders affect the development of blood vessels and lead to heart diseases. Identification of genetic causes can save lives. The technology used for cardiology
Emerging Growth of Global Genomic Medicine Market to 2019-2025| Center for Genom …
Researchmoz (RMOZ) added Most up-to-date research on "Global Genomic Medicine Market Size, Status and Forecast 2019-2025" to its huge collection of research reports. NHGRI defines genomic medicine as "an emerging medical discipline that involves using genomic information about an individual as part of their clinical care and the health outcomes and policy implications of that clinical use." Backed by government investments in precision medicine initiatives such as a multimillion dollar investment by
Global Genomic Biomarker Market Research and Forecast 2018-2023
Global genomic biomarkers market size, share, market intelligence, market trends, research and analysis report by disease indication (oncology, cardiology, neurology) by end users (hospitals, diagnostic and research laboratories) forecast 2018-2023 According to the OMR analysis, the global genomic biomarker market is growing at a moderate rate during 2018-2023. The global genomic biomarker market has witnessed a moderate growth due to increasing cases of chronic diseases and rising healthcare expenditure. The global
Global Genomic Biomarker Market Research and Forecast 2018-2023
“Increasing prevalence of chronic diseases and demand for advanced disease diagnostics is driving the growth of genomic biomarker market.” According to the OMR analysis, the global genomic biomarker market is growing at a moderate rate during 2018-2023. The global genomic biomarker market has witnessed a moderate growth due to increasing cases of chronic diseases and rising healthcare expenditure. The global genomic biomarker market is segmented on the basis of disease indication,
Genomic Medicine Market Detailed Analytical Overview by 2016 - 2026
The National Human Genome Research Institute defines genomic medicine as "an emerging medical discipline that involves using genomic information about an individual as part of their clinical care (e.g., for diagnostic or therapeutic decision-making) and the health outcomes and policy implications of that clinical use." Genomic medicine is a type of precision medicine in which genomics, epigenomics and other related data is used to accurately aid in individual disease diagnosis.
Global Genomic Sequencing Technologies Market US$ 7.2 Billion by 2021
The global genomic sequencing technologies market expected to reach US$ 7.2 billion by 2021, growing at CAGR 14% over the forecast period 2017-2021, mainly due to high-throughput - next generation sequencing technologies, and advances in personalized medicine. Genomic sequencing technologies have revolutionized biology, with impacts ranging from the sequencing of several model genomes to the birth of a new era for pharmacogenomics. In recent years, there has been an increasing fragmentation